Evidence map›Paper›PMID 37023264›Full record

ArticleAmerican journal of respiratory and critical care medicine2023

An ALARMINg Type 2 Response in Cystic Fibrosis-The Key to Understanding ABPA?

Christine M Bojanowski, Jacob P Bitoun, Jay K Kolls

Open access · hybridAbstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of respiratory and critical care medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Pathogenesis and Triazole Resistance inInfection and drug resistance · 2026
    Review
  2. Mesenchymal stromal cell extracellular vesicles reduceAmerican journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  3. Let-7b-5p loaded Mesenchymal Stromal Cell Extracellular Vesicles reducebioRxiv : the preprint server for biology · 2025
    Article
  4. PANoptosis opens new treatment options for allergic bronchopulmonary aspergillosis.The journal of allergy and clinical immunology. Global · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christine M BojanowskiJohn W. Deming Department of Medicine Tulane University School of Medicine New Orleans, Louisiana.
Jacob P BitounDepartment of Microbiology and Immunology Tulane University School of Medicine New Orleans, Louisiana.
Jay K KollsJohn W. Deming Department of Medicine Tulane University School of Medicine New Orleans, Louisiana.
Tulane University · US

Funding

Training in CD4 T-cell Lung ImmunityR35HL139930 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI KOLLS, JAY K · 2018 to 2024
$6.3M
The Role of STa in ETEC PathogenesisR01AI125542 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI BITOUN, JACOB P. · 2017 to 2020
$1.5M
Development of an ETEC multivalent subunit vaccine using outer membrane vesiclesR21AI190682 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI Jacob P. Bitoun · 2025 to 2026
$415k
NHLBI NIH HHS R35 HL139930NIAID NIH HHS R01 AI125542NIAID NIH HHS R21 AI190682
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cystic FibrosisHumansInflammationInterleukin-33Respiratory SystemInterleukin-33

Identifiers

PMID37023264
PMCPMC10263133
OpenAlexW4362659771

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.